Showing results 10 to 12 of 12
< previous
| Title | Author(s) | Issue Date | Views | |
|---|---|---|---|---|
Long-term inhibition of mutant LRRK2 hyper-kinase activity reduced mouse brain α-synuclein oligomers without adverse effects Journal:npj Parkinson's Disease | 2022 | |||
LRRK2 mutant knock-in mouse models: therapeutic relevance in Parkinson's disease Journal:Translational Neurodegeneration | 2022 | 10 | ||
LRRK2, GBA and their interaction in the regulation of autophagy: implications on therapeutics in Parkinson's disease Journal:Translational Neurodegeneration | 2022 | 19 |